Table 1 Demographic and clinical data of participants
Characteristic | Pro DLB | Mild DLB | Pro AD | Mild AD | HC |
|---|---|---|---|---|---|
Participants | 46 | 16 | 13 | 25 | 21 |
Female | 26 | 8 | 4 a | 17 | 12 |
Age, years (SD) | 69.4 (8.8) | 74.7 (10.2) ∗ | 74.5 (9.9) ∗ | 73.6 (9.1) ∗ | 64.8 (8.6) |
MMSE score (SD) (maximum 30) | 27.5 (1.4) | 20.7 (3.4) | 27.1 (1.5) | 19.5 (3.4) | 28.9 (1.0) |
Participants with visual hallucinations | 19 | 9 | 0 | 3 | 0 |
Participants with parkinsonism | 34 | 11 | 1 | 7 | 0 |
Participants with cognitive fluctuations | 28 | 9 | 0 | 5 | 0 |
Medial temporal lobe atrophy (L, R) | |||||
Participants with a score of 0 | 18, 16 | 6, 4 | 3, 3 | 7, 5 | 13, 9 |
Participants with a score of 1 | 11, 12 | 1, 4 | 5, 6 | 5, 9 | 7, 10 |
Participants with a score of 2 | 12, 15 | 4, 4 | 4, 4 | 7, 5 | 1, 2 |
Participants with a score of 3 | 5, 2 | 3, 2 | 1, 0 | 5, 3 | 0, 0 |
Participants with a score of 4 | 0, 1 | 2, 2 | 0, 0 | 1, 3 | 0, 0 |
Parietal lobe atrophy (L, R) | |||||
Participants with a score of 0 | 14, 14 | 9, 8 | 4, 2 | 5, 6 | 7, 8 |
Participants with a score of 1 | 16, 17 | 4, 5 | 7, 8 | 8, 6 | 9, 8 |
Participants with a score of 2 | 12, 11 | 3, 3 | 2, 3 | 9, 9 | 4, 5 |
Participants with a score of 3 | 0, 4 | 4, 0 | 0, 0 | 3, 4 | 0, 0 |
Participants with a score of 4 | 0, 0 | 0, 0 | 0, 0 | 0, 0 | 0, 0 |
Vascular damage in white matter | |||||
Participants with a score of 0 | 25 | 4 | 7 | 9 | 7 |
Participants with a score of 1 | 15 | 7 | 4 | 7 | 12 |
Participants with a score of 2 | 6 | 4 | 1 | 7 | 2 |
Participants with a score of 3 | 0 | 1 | 1 | 2 | 0 |
Vascular damage in basal ganglia | |||||
Participants with a score of 0 | 33 | 13 | 10 | 17 | 21 |
Participants with a score of 1 | 11 | 1 | 2 | 5 | 0 |
Participants with a score of 2 | 2 | 1 | 1 | 0 | 0 |
Participants with a score of 3 | 0 | 1 | 0 | 3 | 0 |
Participants with AchI medication | 14 | 11 | 2 | 17 | 0 |
Participants with dopaminergic medication | 13 | 6 | 0 | 0 | 0 |